Biogen Inc.

07/26/2021 | Press release | Distributed by Public on 07/26/2021 08:04

Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase 1b Study of Lumbar Intrathecal Bolus Administrations of Antisense Oligonucleotide (ISIS[...]